Drug Shortage Report for XYLOCAINE 1% W EPINEPHRINE 1:100000
| Report ID | 220858 |
| Drug Identification Number | 00001791 |
| Brand name | XYLOCAINE 1% W EPINEPHRINE 1:100000 |
| Common or Proper name | lidocaine HCI 1% w/epin. 1:100M 10x20mL MD Vial |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | EPINEPHRINE LIDOCAINE HYDROCHLORIDE |
| Strength(s) | 0.01MG 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | BLOCK/INFILTRATION BLOCK/INFILTRATION |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10 vials |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-06-17 |
| Actual start date | |
| Estimated end date | 2024-06-30 |
| Actual end date | 2024-06-14 |
| Shortage status | Avoided shortage |
| Updated date | 2024-06-14 |
| Company comments | VR44553CA1 XYLOCAIN AD 10MG:10MCG VIL 10X20ML CA AS |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.